Background Strategies to reduce antibiotic overuse in hospitals depend on prescribers taking
decisions to stop unnecessary antibiotic use. There is scarce evidence for how to support …

Background Intensive care unit–acquired muscle weakness (ICUAW) has an incidence of 40–46%.
Early mobilisation is known to be a protective factor. Objective The aim of the study …

Objectives There is limited evidence that empirical antimicrobials affect patient-oriented
outcomes in Gram-negative bacteraemia. We aimed to establish the impact of effective …

Aims There is a lack of biomarkers validated for assessing clinical deterioration in patients
with COVID-19 on presentation to secondary or tertiary care. This evaluation looked at the …

Aim To evaluate the degree of implementation of protocols associated with the prevention of
intensive-care-unit (ICU) acquired muscle weakness, and the presence of the …

Objective To adapt the ICU Mobility Scale (IMS) to the area of intensive care units (ICU) in
Spain and to evaluate the metric properties of the Spanish version of the IMS (IMS-Es). …

Objectives A novel ‘subscription-type’ funding model was launched in England in July 2022
for ceftazidime/avibactam and cefiderocol. We explored the views of infection consultants on …

Objectives The long-term outcomes of patients following Gram-negative bacteraemia (GNB)
are poorly understood. Here we describe a cohort of patients with GNB over a 2-year period …

Objetivo Evaluar el nivel de implementación de los protocolos asociados a la prevención
de la debilidad muscular adquirida en la unidad de cuidados intensivos (UCI), así como la …

Background Strategies to reduce antibiotic overuse in hospitals depend on clinicians taking
decisions to stop unnecessary antibiotics. There is a lack of evidence on how support …